Clinical Trial Update: Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses dose escalation of cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery in patients with unresectable Sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Ovarian Adenocarcinoma, Fallopian Tube Adenocarcinoma | Phase 1 | Status: COMPLETED